Inc.

Opus Genetics, Inc. Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near…

Caitlin Clark, Aliyah Boston on Fever’s offense after loss to Aces The Fever’s offense was solid in the…

Cooper Flagg selected No. 1 by the Dallas Mavericks Bryan Kalbrosky talks about the highly anticipated prospect in…

WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two…

MINNEAPOLIS (AP) — The $1.5 billion sale of the Minnesota Timberwolves from Glen Taylor to an investment group…

CLAYMONT, Del. (AP) — Lawmakers in Texas, Oklahoma and Nevada have recently approved changes aimed at helping their…

Tesla, Inc. (NASDAQ:TSLA) is one of the 10 AI Stocks in the Spotlight. On June 20, Wedbush’s Dan Ives reiterated his…

“Jeff and Shawn’s recruitment is part of our national brokerage expansion plan, which we call ‘Project Gridiron,'” Robert…

Suns new coach Jordan Ott explains how he plans to prove his talent Phoenix Suns news head coach…

What time is the launch for ULA Atlas V, Jeff Bezos-Amazon satellite rocket launch? Liftoff will be from…

Opus Genetics Announces VEGA-3 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia